How can scientific discoveries be translated into new therapies, diagnostics and healthcare innovations? The German Centers for Health Research (DZG) will address this question at BIO-Europe in Cologne from 9 to 11 November 2026. At Booth 7-42, the eight centres will showcase innovative technologies, translational research projects and successful spin-offs, demonstrating how scientific excellence can be translated into tangible benefits for patients more rapidly.
The DZG will also use this international partnering platform to present promising technologies and research approaches to potential development, industry and investment partners. The aim is to initiate new collaborations that accelerate the translation of scientific discoveries into practical solutions for patients.
Representatives from all eight DZG centres will be available for discussions at the joint exhibition stand. Fact sheets will showcase selected technologies, innovations and projects from their respective portfolios. In addition, technology transfer experts will be available for individual meetings and one-to-one partnering discussions on DZG technologies, patents and potential collaboration opportunities.
A highlight of the programme will be the fireside chat session entitled “Cracking the Translation Gap: Lessons from Germany’s Coordinated Translational Research Model.” DZG spokesperson Prof. Stefanie Dimmeler and Prof. Heiko Lickert, a researcher at the German Center for Diabetes Research (DZD) and founder of Viacure GmbH, will discuss how research networks, effective technology transfer and entrepreneurial commitment can help turn scientific breakthroughs into innovative healthcare solutions.
The DZG look forward to engaging with researchers, companies, investors and other stakeholders who are committed to actively shaping the future of medicine.
